Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Baroncelli

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Mutation Research|November 1, 1976
Mutagenicity of industrial compounds: styrene and its possible metabolite styrene oxideN Loprieno, A Abbondandolo, R Barale, et al.
Journal of Medical Primatology|September 14, 2001
Effect of vaccination with recombinant modified vaccinia virus Ankara expressing structural and regulatory genes of SIV(macJ5) on the kinetics of SIV replication in cynomolgus monkeysD R Negri, S Baroncelli, Z Michelini, et al.
Infection|October 29, 2015
HCV-HIV coinfected pregnant women: data from a multicentre study in ItalyS Baroncelli, M F Pirillo, R Amici, et al.
Nature Medicine|June 17, 1999
Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccineA Cafaro, A Caputo, C Fracasso, et al.
Journal of Medical Primatology|November 21, 2000
SHIV89.6P pathogenicity in cynomolgus monkeys and control of viral replication and disease onset by human immunodeficiency virus type 1 Tat vaccineA Cafaro, A Caputo, M T Maggiorella, et al.
International Journal of STD & AIDS|July 31, 2012
Virological failure at one year in triple-class experienced patients switching to raltegravir-based regimens is not predicted by baseline factorsR Bucciardini, G D'Ettorre, S Baroncelli, et al.
Vaccine|April 3, 2001
Vaccination with DNA containing tat coding sequences and unmethylated CpG motifs protects cynomolgus monkeys upon infection with simian/human immunodeficiency virus (SHIV89.6P)A Cafaro, F Titti, C Fracasso, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Mutation Research|November 1, 1976
Mutagenicity of industrial compounds: styrene and its possible metabolite styrene oxideN Loprieno, A Abbondandolo, R Barale, et al.
Journal of Medical Primatology|September 14, 2001
Effect of vaccination with recombinant modified vaccinia virus Ankara expressing structural and regulatory genes of SIV(macJ5) on the kinetics of SIV replication in cynomolgus monkeysD R Negri, S Baroncelli, Z Michelini, et al.
Infection|October 29, 2015
HCV-HIV coinfected pregnant women: data from a multicentre study in ItalyS Baroncelli, M F Pirillo, R Amici, et al.
Nature Medicine|June 17, 1999
Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccineA Cafaro, A Caputo, C Fracasso, et al.
Journal of Medical Primatology|November 21, 2000
SHIV89.6P pathogenicity in cynomolgus monkeys and control of viral replication and disease onset by human immunodeficiency virus type 1 Tat vaccineA Cafaro, A Caputo, M T Maggiorella, et al.
International Journal of STD & AIDS|July 31, 2012
Virological failure at one year in triple-class experienced patients switching to raltegravir-based regimens is not predicted by baseline factorsR Bucciardini, G D'Ettorre, S Baroncelli, et al.
Vaccine|April 3, 2001
Vaccination with DNA containing tat coding sequences and unmethylated CpG motifs protects cynomolgus monkeys upon infection with simian/human immunodeficiency virus (SHIV89.6P)A Cafaro, F Titti, C Fracasso, et al.
Pageof 3